Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Abstract

Background Etanercept and methotrexate are effective in the treatment of rheumatoid arthritis but no data exist on concurrent initiation or use of the combination compared with either drug alone. We aimed to assess combination treatment with etanercept and methotrexate versus the monotherapies in patients with rheumatoid arthritis. Methods In a double-blind, randomised, clinical efficacy, safety, and radiographic study, 686 patients with active rheumatoid arthritis were randomly allocated to treatment with etanercept 25 mg (subcutaneously twice a week), oral methotrexate (up to 20 mg every week), or the combination. Clinical response was assessed by criteria of the American College of Rheumatology (ACR). The primary efficacy endpoint was the numeric index of the ACR response (ACR-N) area under the curve (AUC) over the first 24 weeks. The primary radiographic endpoint was change from baseline to week 52 in total joint damage and was assessed with the modified Sharp score. Analysis was by intention to treat. Findings Four patients did not receive any drug; thus 682 were studied. ACR-N AUC at 24 weeks was greater for the combination group compared with etanercept alone and methotrexate alone (18.3%-years [95% CI 17.1-19.6] vs 14.7%-years [13.5-16.0], p Interpretation The combination of etanercept and methotrexate was significantly better in reduction of disease activity, improvement of functional disability, and retardation of radiographic progression compared with methotrexate…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)15640-7

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Research works printed but not linked: 1

  1. Weinblatt, 1999, The role of current strategies in the future treatment of rheumatoid arthritis, Rheumatology, 38, 19

Cited by

See all 1,751

Metadata

Authors
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., Wajdula, J., Pedersen, R., Fatenejad, S., & Sanda, M.
Affiliations
  • Karolinska University Hospital (SE)
  • Harrogate District Hospital (GB)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Centre Hospitalier Universitaire de Liège (BE)
  • Hospital Universitario La Paz (ES)
  • Hôpital Lapeyronie (FR)
  • Aristotle University of Thessaloniki (GR)
  • Wyeth (US)
Corresponding author
Klareskog, Lars
Venue
The Lancet
Publisher
Elsevier BV
Published
2004-02
Volume
363
Issue
9410
Pages
675-681
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2116843833
Cited by
1,751
References
39
Citations by year
2026: 9 · 2025: 17 · 2024: 17 · 2023: 24 · 2022: 30 · 2021: 32 · 2020: 39 · 2019: 41 · 2018: 65 · 2017: 58 · 2016: 72 · 2015: 92 · 2014: 89 · 2013: 101 · 2012: 99
FWCI
89.16
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • ORBi (University of Liège) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
  • Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords
rheumatoid arthritis, etanercept, methotrexate, combination therapy, TNF-alpha inhibitors, disease-modifying antirheumatic drugs, ACR response, joint destruction, modified Sharp score, radiographic progression, treatment efficacy and safety, monotherapy comparison, adverse events, drug interactions, drug discontinuation, patient-reported outcomes, health-related quality of life
MeSH terms
Etanercept, Arthritis, Rheumatoid, Arthrography, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Immunoglobulin G, Male, Methotrexate, Middle Aged, Recombinant Fusion Proteins, Treatment Outcome, Receptors, Tumor Necrosis Factor, Antirheumatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(04)15640-7
The paper
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., Wajdula, J., Pedersen, R., Fatenejad, S., & Sanda, M. (2004). Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(04)15640-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.